23948sdkhjf
  1. Udbud
  2. Social og sundhedsvæsen
  3. Lægemidler

Fakta om udbudet

EU-nr
2019/S 016-033725
Offentliggjort
23.01.2019
Udbudstype
Opdatering

Udbyder

Uppsala universitet

Procurement of Study Drug for Clinical Trial

Uppsala universitet

Corrigendum

Notice for changes or additional information

Supplies

(Supplement to the Official Journal of the European Union, 2018/S 246-563284)

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority/entity

I.1) Name and addresses
Uppsala universitet
202100-2932
Uppsala universitet Dag Hammarskjölds väg 7
Uppsala
752 37
Sweden
Contact person: Annika Vretman
Telephone: +46 184717134
E-mail: annika.vretman@uadm.uu.se
NUTS code: SE121

Internet address(es):

Main address: https://uu.se/

Section II: Object

II.1) Scope of the procurement
II.1.1) Title:

Procurement of Study Drug for Clinical Trial

Reference number: UH 2018/91
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description:

The purpose of the procurement is to acquire drugs for a clinical trial. The trial drugs are metformin 500 mg and placebo. The trial runs over 24 months for each subject and is expected to be completed within 3 years of study start. The subjects will be randomized to metformin 500 mg x 3 or placebo x 3 in a 1:1 ratio in a double blind fashion. Approximately 525 000 doses respectively of metformin 500 mg and placebo is needed to provide a 20 % surplus of drugs to ensure that each site have sufficient amounts of drugs while recruiting patients.

Section VI: Complementary information

VI.5) Date of dispatch of this notice:
21/01/2019
VI.6) Original notice reference
Notice number in the OJ S: 2018/S 246-563284

Section VII: Changes

VII.1) Information to be changed or added
VII.1.2) Text to be corrected in the original notice
Section number: IV.2.2)
Place of text to be modified: Time limit for receipt of tenders or requests to participate
Instead of:
Date: 27/01/2019
Read:
Date: 31/01/2019
Section number: IV.2.7)
Place of text to be modified: Conditions for opening of tenders
Instead of:
Date: 28/01/2019
Read:
Date: 01/02/2019
Section number: II.1.4)
Place of text to be modified: Short description
Instead of:

The purpose of the procurement is to acquire drugs for a clinical trial. The trial drugs are metformin 500 mg and placebo. The trial runs over 24 months for each subject and is expected to be completed within 3 years of study start. The subjects will be randomized to metformin 500 mg x 3 or placebo x 3 in a 1:1 ratio in a double blind fashion. Approximately 400 000 doses respectively of metformin 500 mg and placebo is needed to provide a 20 % surplus of drugs to ensure that each site have sufficient amounts of drugs while recruiting patients.

Read:

The purpose of the procurement is to acquire drugs for a clinical trial. The trial drugs are metformin 500 mg and placebo. The trial runs over 24 months for each subject and is expected to be completed within 3 years of study start. The subjects will be randomized to metformin 500 mg x 3 or placebo x 3 in a 1:1 ratio in a double blind fashion. Approximately 525 000 doses respectively of metformin 500 mg and placebo is needed to provide a 20 % surplus of drugs to ensure that each site have sufficient amounts of drugs while recruiting patients.

VII.2) Other additional information:

Send til en kollega

0.078